1. Home
  2. MRSN vs SYT Comparison

MRSN vs SYT Comparison

Compare MRSN & SYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • SYT
  • Stock Information
  • Founded
  • MRSN 2001
  • SYT 2010
  • Country
  • MRSN United States
  • SYT Japan
  • Employees
  • MRSN N/A
  • SYT N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • SYT Real Estate
  • Sector
  • MRSN Health Care
  • SYT Finance
  • Exchange
  • MRSN Nasdaq
  • SYT Nasdaq
  • Market Cap
  • MRSN 40.7M
  • SYT 41.2M
  • IPO Year
  • MRSN 2017
  • SYT 2023
  • Fundamental
  • Price
  • MRSN $0.32
  • SYT $1.84
  • Analyst Decision
  • MRSN Buy
  • SYT
  • Analyst Count
  • MRSN 3
  • SYT 0
  • Target Price
  • MRSN $4.00
  • SYT N/A
  • AVG Volume (30 Days)
  • MRSN 2.3M
  • SYT 6.6K
  • Earning Date
  • MRSN 05-15-2025
  • SYT 05-20-2025
  • Dividend Yield
  • MRSN N/A
  • SYT 0.33%
  • EPS Growth
  • MRSN N/A
  • SYT N/A
  • EPS
  • MRSN N/A
  • SYT 0.08
  • Revenue
  • MRSN $40,497,000.00
  • SYT $149,124,408.00
  • Revenue This Year
  • MRSN N/A
  • SYT N/A
  • Revenue Next Year
  • MRSN N/A
  • SYT N/A
  • P/E Ratio
  • MRSN N/A
  • SYT $25.78
  • Revenue Growth
  • MRSN 9.88
  • SYT 3.11
  • 52 Week Low
  • MRSN $0.26
  • SYT $1.18
  • 52 Week High
  • MRSN $3.50
  • SYT $3.90
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 41.87
  • SYT 32.97
  • Support Level
  • MRSN $0.35
  • SYT $1.60
  • Resistance Level
  • MRSN $0.44
  • SYT $2.50
  • Average True Range (ATR)
  • MRSN 0.04
  • SYT 0.19
  • MACD
  • MRSN -0.00
  • SYT -0.05
  • Stochastic Oscillator
  • MRSN 8.48
  • SYT 26.70

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About SYT SYLA Technologies Co. Ltd.

SYLA Technologies Co Ltd is a property technology company. It provides asset management platform systems that facilitate real estate crowd-funding as well as the purchase and sale of real estate.

Share on Social Networks: